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Abstract
Single strain probiotic bifidobacteria approach is promising for the future in 
health and non-health fields. Recent studies show that intestinal lumen microbial 
content and tissue microbial content are different, so the personalized microbi-
ome approach with the 16S rRNA analysis comes to the fore with the single strain 
probiotic bifidobacteria (BB-12,Infantis) approach. In addition to their immune 
modulation effect, they have beneficial effects such as preventing pathogens from 
binding to the intestinal mucosa via the biofilm layer they produce, and also their 
electrophysical properties in various atmospheric conditions, They have the ability 
to be used in non-health areas such as microplastic biodegradition, nanostructures, 
food and agriculture fields. The availability of single strain probiotic bifidobacteria 
in health, ecological and food systems are signs that progress in the single strain 
probiotic bacteria approach will be more accurate.
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1. Introduction
Probiotic bifidobacteria are living microorganisms that have beneficial immu-
nomodulatory effects on human health and have fermentation properties. They 
can play a role in the management of dysbiosis-related intestinal disorders such as 
colon cancer, IBD, Celiac, IBS, as well as virological disorders such as SARS-Cov-2 
and neurologic disorders. Although there are many scientific studies on the effects 
of single strain of probiotic bifidobacteria on human health, there are very few 
publications on their behavior and interactions in various atmospheric conditions 
other than the human body. In this section, we present the effects of single strain of 
probiotic bifidobacteria approach in the field of health, as well as the electrophysi-
ological behaviors and interactions in various atmospheric conditions with different 
materials.
1.1 Single strain of probiotic Bifidobacteria approach in the field of health
1.1.1 Single strain of probiotic Bifidobacteria in gastrointestinal disorders
As we discussed in detail in our previous work [1], the human intestinal micro-
biota includes commensal, symbiotic, and pathogenic bacteria species [2, 3]. It 
was demonstrated that intestinal microbiota have anti-inflammatory features and 
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contribute to the immune, neuroendocrine, and metabolic homeostasis of the host 
[4, 5]. The genus Bifidobacterium in gut microbiota is Gram-positive, non-motile, 
often branched anaerobic bacteria and it belongs to the phylum Actinobacteria [1]. 
Bifidobacteria are one of the dominant species in the human gut microbiota and are 
frequently used as probiotics [6]. B. animalis subsp. lactis exerts the highest level 
of intracellular hydrogen peroxide resistance among Bifidobacteria and provide 
protection against reactive cellular oxygen species [7]. Reduced bifidobacteria levels 
are associated with inflammatory bowel disease (IBD) [8, 9]. B. infantis 35624 has 
been shown that reduced plasma pro-inflammatory biomarkers in IBD and extra-
intestinal inflammatory disorders [10].
Also, the administration of B. infantis 35624 was associated with a significant 
reduction in plasma pro-inflammatory biomarkers in patients with psoriatic dis-
order and oral administration of B. infantis 35624 modulates the cytokine across 
both gastrointestinal and non-gastrointestinal inflammatory disorders and 
healthy subjects. In our previous study [11], endoscopic single Bifidobacterium 
animalis subsp. lactis and xyloglucan administration was found effective in the 
mucosal healing and resolution of colonic symptoms in ulcerative colitis patients 
(Figures 1 and 2) [11].
Figure 1. 
Mucosal healing (upper) within one month after a single intracolonic application of 200 billion colony forming 
units (CFUs) of Bifidobacterium animalis sp. Lactis and 4 gr Xyloglucan combination in unresponsive 
ulcerative colitis (below) [11].
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The use of single strain probiotic bifidobacteria such as BB-12 and Infantis in 
effective and appropriate doses can be considered an effective treatment method for 
intestinal and extraintestinal disorders.
Another aspect of the single strain probiotic bifidobacteria is that they are 
suitable candidates for the next generation probiotic. As we discussed in detail our 
previous study [1], With the Open Reading Frame (ORF) method, these species can 
be guided by genetic coding for postbiotic production [12]. Mycosporin amino acids 
are a viable target for this situation. Mycosporin-like amino acids (MAAs) are low 
molecular weight amino acids. MAAs act as absorbers of ultraviolet (UV) light and 
as photo protectants which are unique components of red seaweeds [13]. Seaweed 
products are used as nutritional supplements in the management of bowel diseases. 
Figure 2. 
Mucosal healing (below) within one month after a single intracolonic application of 200 billion colony forming 
units (CFUs) of Bifidobacterium animalis sp. Lactis and 4 gr Xyloglucan combination in unresponsive 
ulcerative proctosigmoid colitis (upper) [11].
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MAAs also play a key role in protecting against sunlight damage by acting as 
antioxidant molecules scavenging toxic oxygen radicals. MAAs have been described 
to affect the intestinal mucosa, enhancing villus structure, as well as the intestinal 
microbiota, increasing the abundance of Bifidobacterium and, importantly, reduc-
ing the prevalence of Clostridium species in animal models [14]. Also, modulation 
of NF-κB and tryptophan metabolism via MAAs has a beneficial effect on the gut 
immune system. Besides these features, MAAs also inhibit thiobarbituric acid reac-
tive oxygen species which are increased in colon cancer.
In this context, MAA-producing single strain Bifidobacteria species via ORF 
could result in a bacterium that is more potent in the prevention of dysbiosis associ-
ated disorders such as IBD, CRC, Chronic inflammation. Also, MAAs produced via 
ORF might be used not only as a probiotic but also as a pharmacological agent in 
intestinal disorders.
1.1.2 Single strain probiotic Bifidobacteria in Sars-Cov-2 management
As we reported in our previous study [15], Sars-Cov-2 is a pandemic virus that 
manifests itself with respiratory distress as well as leading to symptoms and signs 
associated with the gastrointestinal tract. Sars-Cov-2 is especially manifested 
by the disturbed adaptive immune status in lung and intestinal tissues which is 
called ‘cytokine storm’. During their cellular replication, viral pathogens such 
as Sars-Cov-2 increase endoplasmic reticulum stress and exert their autophagy 
inducing effects through the adaptive TH17 / IL17 system and this leads to an 
uncontrolled immune response [15]. The cytokine storm can be modulated through 
immune effects of strain specific probiotic bifidobacteria. In our previous study, 
Bifidobacterium animalis sp. Lactis-BB12 led to rapid mucosal healing in ulcerative 
colitis patients [11] and this effect was related to the IL-17 inhibitory effect of 
the BB-12 strain. IL-6 promotes the generation of Th17 cells and that IL-6 and 
IL-17 synergistically promote viral replication and B. infantis 35624 could reduce 
the systemic inflammatory biomarkers such as IL-6,CRP, TNF alpha [15]. Also, 
Bifidobacterium infantis reduced the duration of acute respiratory infections illness 
in children and adults [16]. The administration of booster of an appropriate strain 
of bifidobacterium (such as BB-12, or infantis) especially in patients with gastroin-
testinal symptoms (diarrhea, abdominal pain, vomiting), may be postulated to have 
a role in the management of coronavirus infected patients (Figure 3).
1.1.3 Single strain probiotic Bifidobacteria in vaccine development
Gut dysbiosis might play a role in the failure to respond to vaccines. In this 
regard, gut microbiota could affect intestinal immune responses by acting as 
Figure 3. 
Rapid radiologic enhancement of high dose oral Bifidobacterium BB-12 administration in severe  
Sars-Cov-2 [15].
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immune modulators as well as natural vaccine adjuvants [17]. The administration of 
the probiotic strain Bifidobacterium BB-12 significantly increased antigen-specific 
immune responses in healthy individuals receiving influenza vaccination [18]. 
Also, Exopolysaccharide produced by B. longum 35624 played an essential role in 
the anti-inflammatory effects of this bacterium and removal of exopolysaccharide 
(EPS) resulted, not only in loss of these anti-inflammatory effects, but to a trans-
formation to become an inducer of local TH17 responses [19]. In some experiments, 
EPS- protein conjugate vaccines could enhance immunogenity [20]. Our studies 
revealed that the maintenance of the unique electrophysiological properties of 
BB-12,Infantis in an aerobic environment for up to 6 months could be attributed to 
the integrity of their unique EPS structure [21]. Hence, the single strain probiotic 
bifidbacterial polysaccharide cell structure can be considered as a lipopeptide based 
vaccines.
Since the relationship between viral replication and gastrointestinal immunity is 
very close, an appropriate approach over probiotic bifid bacteria can play an impor-
tant role in reducing viral replication. New approaches to the single strain probiotic 
bacteria can be promising, both in terms of vaccination and treatment models.
2. Single strain probiotic Bifidobacteria in non-health fields
2.1 Electrophysiological properties of Bifidobacterium BB12 and infantis
2.1.1 Bifidobacterium BB-12
As we cited in our previous study [1], BB-12 is technologically well suited, 
expressing fermentation activity, high aerotolerance, good stability and a high acid 
and bile tolerance. Because of high redox potential in the colon microbiota ecosys-
tem, BB-12 is highly resistant bacteria in distress condition. The BB-12 cell envelope 
is an electrical and physical barrier that that consist of redox proteins. Bacterial 
cellular electron transfer systems (CET) are defined microbial bioelectrochemical 
processes in which electrons are transferred from the cytosol to the membrane of 
the cell [22, 23]. Charge transport behavior and the effect of the Relative Humidity 
(RH) level on it in the BB-12 film have been investigated by means of I-V measure-
ments. Within aqua moisture environment, electrical conductivity of the BB-12 
increased more than six decades while under N environment conductivity returns 
to the initial current value (Figure 4).
This behavior in conductivity modulation was reversible at least in the three 
cycle [21].
As we stated in our study [21], this experimental findings showed us that there 
was no structural transformation under relative humidity. On the other side, 
increase in the conductivity was interpreted by the increase in the population of 
charge carries, supplied by the interaction BB-12 with the water moisture, monitored 
by amine and carboxyl group through FTIR and Zeta potential measurements. The 
type of surface charge of Bifidobacterium animalis subsp. lactis BB-12 was found to 
be negative by zeta potential measurements, claiming that electrons were the charge 
carriers. Overall, obtained result in this study indicated that Bifidobacterium BB-12 
has a great potential for humidity sensing device at room temperature.
2.1.2 Bifidobacterium Infantis
B. infantis 35624 is probiotic commensal bacteria that dominates the intestinal 
microbiota of breastfed babies and by accelerating and balancing the maturation of 
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the system and that improves intestinal barrier function and also benefits the host 
by increasing acetate production (Figure 5).
Interaction of aqua molecules with the surface of the Bifidobacterium infantis film 
leads to an increase. Increase in sensor current to a nearly constant value within a few 
minutes. Increase in sensor current, with aqua molecules, the interaction between 
bifidobacteria and aqua is highly dependent on the molecular structure of the assays.
Sensor sensitivity increases with the increase in relative humidity, aqua on the 
film surface reveals that adsorption of molecules is a multilayer process. Room 
linear increase in sensitivity with relative humidity, sensors 0–90% relative humid-





I–V characteristics of the film of Bifidobacterium animalis subsp. lactis BB-12 at various RH levels.
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3. Future approaches with single strain probiotic Bifidobacteria
Infection of medical equipment is one of the most common problems in the 
healthcare field, medical equipment infection can be prevented by probiotic bifido-
bacterial adhesion (Figure 7). Also, depending on the electrophysiological proper-
ties of these single strain probiotic bifidobacteria species, which have antimicrobial, 
Figure 6. 
Response-recovery behavior of Bifidobacterium infantis-based sensor for various RH levels.
Figure 7. 
Single strain probiotic bifidobacteria adhesion on medical orthopedic implant on scanning electron microscope 
(SEM) appearance.
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immunomodulatory and beneficial effects on human health, they have paved 
the way for a new era in many areas such as agriculture, food, biodegradation of 
microplastics (Figure 8) and a healthy ecological system.
4. Conclusion
Single strain probiotic bifidbacteria approach is a promising approach in cases 
such as inflammatory bowel diseases, bowel disorders, virological disorders and 
colon cancer. Beside these, single strain probiotic bifidobacteria approach is promis-
ing for a healthy ecosystem depending on its behavior in atmospheric conditions.
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Figure 8. 
Single strain probiotic bifidobacteria adhesion (left appearance of SEM) and biodegradation (right 
appearance of SEM EDS) on polypropylene microplastic.
9
Single Strain Probiotic Bifidobacteria Approach in Health and Non-Health Fields
DOI: http://dx.doi.org/10.5772/intechopen.99712
Author details
Hüseyin Sancar Bozkurt1* and Havva Bozkurt2
1 Clinic of Gastroenterology, Internal Medicine, Medicine Faculty, Maltepe 
University, Istanbul, Turkey
2 Medicine Laboratuary, İstanbul, Turkey
*Address all correspondence to: sancarb79@gmail.com
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Prebiotics and Probiotics - From Food to Health
10
References
[1] Bozkurt, H.S.; Quigley, E.M.; Kara, 
B. Bifidobacterium animalis subspecies 
lactis engineered to produce 
mycosporin-like amino acids in 
colorectal cancer prevention. SAGE 
Open Med. 2019, 7.
[2] The NIH HMP Working Group; 
Peterson, J.; Garges, S.; Giovanni, M.; 
McInnes, P.; Wang, L.; Schloss, J.A.; 
Bonazzi, V.; McEwen, J.E.; 
Wetterstrand, K.A.; et al. The NIH 
Human Microbiome Project. Genome 
Res. 2009, 19, 2317-2323.
[3] Sherwood, L.; Willey, J.; Woolverton, 
C.J. Prescott’s Microbiology, 9th ed.; 
McGraw-Hill Education: New York, NY, 
USA, 2013; pp. 713-721
[4] 4.Cahenzli, J.; Balmer, M.L.; McCoy, 
K.D. Microbial-immune cross-talk and 
regulation of the immune system. 
Immunology 2012, 138, 12-22.
[5] Sunkara, T.; Rawla, P.; Ofosu, A.; 
Gaduputi, V. Fecal microbiota 
transplant—A new frontier in 
inflammatory bowel disease. J. Inflamm. 
Res. 2018, 11, 321-328.
[6] Bozkurt, H.S.; Quigley, E.M.M. 
Bifidobacteria and Mucosal-Associated 
Invariant T (MAIT) Cells: A New 
Approach to Colorectal Cancer 
Prevention? Gastrointest. Disord. 2019, 
1, 266-272.
[7] Oberg, T.S.; Steele, J.L.; Ingham, S.C.; 
Smeianov, V.V. Intrinsic and inducible 
resistance to hydrogen peroxide in 
Bifidobacterium species. J. Ind. 
Microbiol. Biotechnol. 2011, 38, 
1947-1953.
[8] 8.Hughes, K.R.; Harnisch, L.C.; 
Alcon-Giner, C.; Mitra, S.; Wright, C.J.; 
Ketskemety, J.; van Sinderen, D.; 
Watson, A.J.; Hall, L.J. Bifidobacterium 
breve reduces apoptotic epithelial cell 
shedding in an exopolysaccharide and 
MyD88-dependent manner. Open Biol. 
2017, 7, 1.
[9] Duranti, S.; Gaiani, F.; Mancabelli, 
L.; Milani, C.; Grandi, A.; Bolchi, A.; 
Santoni, A.; Lugli, G.A.; Ferrario, C.; 
Mangifesta, M.; et al. Elucidating the 
gut microbiome of ulcerative colitis: 
Bifidobacteria as novel microbial 
biomarkers. FEMS Microbiol. Ecol. 
2016, 92.
[10] David Groeger, Liam O’Mahony, 
Eileen F. Murphy, John F. Bourke, 
Timothy G. Dinan, Barry Kiely, Fergus 
Shanahan & Eamonn M.M. Quigley 
(2013) Bifidobacteriuminfantis 35624 
modulates host inflammatory processes 
beyond the gut, Gut Microbes, 4: 4, 
325-339.
[11] 11.Bozkurt HS, Kara B. A new 
treatment for ulcerative colitis: 
Intracolonic Bifidobacterium and 
xyloglucan application. European 
Journal of Inflammation. January 2020. 
doi:10.1177/2058739220942626.
[12] Bozkurt HS, Quigley EM, Kara B. 
Bifidobacterium animalis subspecies 
lactis engineered to produce 
mycosporin-like amino acids in 
colorectal cancer prevention. SAGE 
Open Med. 2019;7:2050312119825784. 
Published 2019 Jan 22. 
doi:10.1177/2050312119825784.
[13] Llewellyn CA, Airs RL. Distribution 
and abundance of MAAs in 33 species of 
microalgae across 13 classes. Mar Drugs 
2010; 8(4): 1273-1291.
[14] Cian RE, Drago SR, de Medina FS, 
et al. Proteins and carbohydrates from 
red seaweeds: evidence for beneficial 
effects on gut function and microbiota. 
Mar Drugs 2015; 13(8): 5358-5383
[15] Bozkurt HS, Quigley EM. The 
probiotic Bifidobacterium in the 
management of Coronavirus: A 
11
Single Strain Probiotic Bifidobacteria Approach in Health and Non-Health Fields
DOI: http://dx.doi.org/10.5772/intechopen.99712
theoretical basis. International Journal 
of Immunopathology and 
Pharmacology. January 2020. 
doi:10.1177/2058738420961304.
[16] King, S, Glanville, J, Sanders, ME, et 
al. (2014) Effectiveness of probiotics on 
the duration of illness in healthy 
children and adults who develop 
common acute respiratory infectious 
conditions: A systematic review and 
meta-analysis. British Journal of 
Nutrition 112(1): 41-54.
[17] Ciabattini A, Olivieri R, Lazzeri E, 
et al. (2019) Role of the microbiota in 
the modulation of vaccine immune 
responses. Frontiers in Microbiology 
10: 1305.
[18] Rizzardini G, Eskesen D, Calder PC, 
et al. (2012) Evaluation of the immune 
benefits of two probiotic strains 
Bifidobacterium animalis ssp. lactis, 
BB-12 and Lactobacillus paracasei ssp. 
paracasei,L. casei 431w in an influenza 
vaccination model: A randomised, 
double-blind,placebo-controlled study. 
British Journal of Nutrition 107(6): 
876-884.
[19] Schiavi E, Gleinser M, Molloy E, et 
al. (2016) The surface-associated 
exopolysaccharide of Bifidobacterium 
longum 35624 plays an essential role in 
dampening host proinflammatory 
responses and repressing local TH17 
responses. Applied and Environmental 
Microbiology 82(24): 7185-7196.
[20] Lee CJ, Lee LH, Lu CS, et al. (2001) 
Bacterial polysaccharides as vaccines—
immunity and chemical 
characterization. Advances in 
Experimental Medicine and Biology 491: 
453-471.
[21] Bozkurt K, Denktas C, Ozdemir O, 
et al. (2019) Charge Transport in 
Bifidobacterium animalis subsp. lactis 
BB-12 under various Atmospheres. 
Open Journal of Applied Sciences 9(6): 
506-514.
[22] Shi, L., Dong, H., Reguera, G., 
Beyenal, H., Lu, A., Liu, J., Yu, H.Q. and 
Fredrickson, J.K. (2016) Extracellular 
Electron Transfer Mechanisms between 
Microorganisms and Minerals. Nature 
Reviews Microbiology, 14, 651-662.
[23] Light, S.H., Su, L., Rivera-Lugo, R., 
Cornejo, J.A. and Louie, A. (2018) A 
Flavin-Based Extracellular Electron 
Transfer Mechanism in Diverse Gram-
Positive Bacteria. Nature, 562, 140-144.
